VNRX
AMEX
$1.11
VolitionRX Ltd (VNRX)
VolitionRx Limited, a multinational epigenetics company, is dedicated to developing blood tests to help diagnose a variety of cancers and other diseases globally. The company is headquartered in Austin, Texas.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $16.97 (+1428.83%)
Market Cap
$11M
Revenue 5Y CAGR
+129.88%
Beta (5Y)
0.70
Price Chart
Valuation
Market Cap$11M
Forward P/E20.83
P/S6.91
P/B38.44
Profitability
Total Revenue (TTM)$2.47M
Gross Profit (TTM)$2.47M
EBITDA-$21M
Operating Margin-543%
EPS-$4.03
Financial Health
Debt-to-Equity-22.8%
Growth & Risk
EPS 5Y CAGR-13.69%
Revenue 5Y CAGR+129.88%
FCF 5Y CAGR+0.17%
Beta (5Y)0.70
Sharpe Ratio-2.31